Sharma A, Becker F, Tao X, Baddela V, Koczan D, Ludwig C
BMC Vet Res. 2024; 20(1):439.
PMID: 39342193
PMC: 11438404.
DOI: 10.1186/s12917-024-04275-6.
Benvenga S, Russo M, Forte G, Unfer V
J Clin Transl Endocrinol. 2024; 37:100368.
PMID: 39308767
PMC: 11414692.
DOI: 10.1016/j.jcte.2024.100368.
Podgrajsek R, Ban Frangez H, Stimpfel M
Int J Mol Sci. 2024; 25(7).
PMID: 38612425
PMC: 11011890.
DOI: 10.3390/ijms25073613.
Zaniker E, Zhang M, Hughes L, Follette L, Atazhanova T, Trofimchuk A
Biol Reprod. 2024; 110(6):1100-1114.
PMID: 38609185
PMC: 11180622.
DOI: 10.1093/biolre/ioae050.
Wang Z, van Faassen M, Groen H, Cantineau A, Van Oers A, Van der Veen A
Hum Reprod. 2024; 39(5):1078-1088.
PMID: 38503490
PMC: 11063562.
DOI: 10.1093/humrep/deae058.
Reassessing the impact of letrozole co-administration in controlled ovarian hyperstimulation: findings from a single-center repeated measures study.
Jain N, Licciardi F, Kalluru S, McCulloh D, Blakemore J
J Assist Reprod Genet. 2024; 41(4):979-987.
PMID: 38381391
PMC: 11052955.
DOI: 10.1007/s10815-024-03067-z.
Causal association of immune cells and polycystic ovarian syndrome: a Mendelian randomization study.
Aru N, Yang C, Chen Y, Liu J
Front Endocrinol (Lausanne). 2024; 14:1326344.
PMID: 38189053
PMC: 10770856.
DOI: 10.3389/fendo.2023.1326344.
Stem-Cell-Derived Extracellular Vesicles: Unlocking New Possibilities for Treating Diminished Ovarian Reserve and Premature Ovarian Insufficiency.
Martirosyan Y, Silachev D, Nazarenko T, Birukova A, Vishnyakova P, Sukhikh G
Life (Basel). 2023; 13(12).
PMID: 38137848
PMC: 10744991.
DOI: 10.3390/life13122247.
The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities.
Shen L, Liu J, Luo A, Wang S
J Ovarian Res. 2023; 16(1):237.
PMID: 38093329
PMC: 10717903.
DOI: 10.1186/s13048-023-01300-4.
A new tissue-agnostic microfluidic device to model physiology and disease: the lattice platform.
Campo H, Zha D, Pattarawat P, Colina J, Zhang D, Murphy A
Lab Chip. 2023; 23(22):4821-4833.
PMID: 37846545
PMC: 11181516.
DOI: 10.1039/d3lc00378g.
Dynamic mRNA expression during chicken ovarian follicle development.
Kui H, Li P, Wang T, Luo Y, Ning C, Li M
G3 (Bethesda). 2023; 14(1).
PMID: 37832513
PMC: 10755205.
DOI: 10.1093/g3journal/jkad237.
Hyperandrogenism and Its Possible Effects on Endometrial Receptivity: A Review.
Yusuf A, Amri M, Ugusman A, A Hamid A, Abdul Wahab N, Mokhtar M
Int J Mol Sci. 2023; 24(15).
PMID: 37569402
PMC: 10419014.
DOI: 10.3390/ijms241512026.
Effects of resveratrol on polycystic ovarian syndrome: a systematic review and meta-analysis of randomized controlled trials.
Larik M, Ahmed A, Khan L, Iftekhar M
Endocrine. 2023; 83(1):51-59.
PMID: 37568063
DOI: 10.1007/s12020-023-03479-4.
Metabolic Mechanisms and Potential Therapeutic Targets for Prevention of Ovarian Aging: Data from Up-to-Date Experimental Studies.
Valtetsiotis K, Valsamakis G, Charmandari E, Vlahos N
Int J Mol Sci. 2023; 24(12).
PMID: 37372976
PMC: 10298538.
DOI: 10.3390/ijms24129828.
Effects of intestinal flora on polycystic ovary syndrome.
Liu J, Liu Y, Li X
Front Endocrinol (Lausanne). 2023; 14:1151723.
PMID: 36967808
PMC: 10036050.
DOI: 10.3389/fendo.2023.1151723.
Effect of basal serum testosterone level on the ovarian response and the cumulative live birth rate in infertile women undergoing in vitro fertilization.
Wan R, Ko J, Yung S, Ng E, Li R
J Assist Reprod Genet. 2023; 40(4):883-890.
PMID: 36856970
PMC: 10224885.
DOI: 10.1007/s10815-023-02749-4.
Pregnancy outcomes in patients with polycystic ovary syndrome who conceived after single thawed blastocyst transfer: a propensity score-matched study.
Jie H, Zhou X, Zhao M, Hu M, Mai Q, Zhou C
BMC Pregnancy Childbirth. 2022; 22(1):718.
PMID: 36127673
PMC: 9487057.
DOI: 10.1186/s12884-022-05011-4.
The role of Kisspeptin signaling in Oocyte maturation.
Masumi S, Lee E, Dilower I, Upadhyaya S, Chakravarthi V, Fields P
Front Endocrinol (Lausanne). 2022; 13:917464.
PMID: 36072937
PMC: 9441556.
DOI: 10.3389/fendo.2022.917464.
The organotin triphenyltin disrupts cholesterol signaling in mammalian ovarian steroidogenic cells through a combination of LXR and RXR modulation.
Pu Y, Ticiani E, Pearl S, Martin D, Veiga-Lopez A
Toxicol Appl Pharmacol. 2022; 453:116209.
PMID: 35998708
PMC: 9993406.
DOI: 10.1016/j.taap.2022.116209.
An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry.
Gargus E, Bae Y, Chen J, Moss K, Ingram A, Zhang J
Biomedicines. 2022; 10(7).
PMID: 35884951
PMC: 9313004.
DOI: 10.3390/biomedicines10071646.